RT @ArthurRheum: OLE data shows Tx with Sarilumab improved likelihood of glucocorticoid dose reduction with 16% able to discontinue @RheumN…
Tweet Content
OLE data shows Tx with Sarilumab improved likelihood of glucocorticoid dose reduction with 16% able to discontinue @RheumNow #ACR19 https://t.co/YWetjp5Rlp
Show on Archive Page
On
Display in Search Results
On